165 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
workforce representation and increased community engagement by the company's employees;
◦Advancing climate action goals and increasing the company's
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
or indirectly.
According to the depositary, the foregoing information with respect to the depositary has been provided to the financial community
424B2
t3eyhf704o1erkgn
13 Feb 24
Prospectus for primary offering
8:00am
DFAN14A
wq2 11tv9mxpu
22 Dec 23
Additional proxy materials by non-management
4:36pm
424B5
ryibhso4b19k0sy4f7
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
lmru2n8w1m9
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
evev2veevner9erhvk
10 Apr 23
Additional proxy soliciting materials
5:12pm
424B5
0gbu i1eejqjgk
17 Feb 22
Prospectus supplement for primary offering
4:47pm
424B3
qr43 ems1104gyi
15 Feb 22
Prospectus supplement
9:13am
8-K
EX-99.1
g0k9jdmsdlmu
16 Nov 21
Regulation FD Disclosure
9:20am